Literature DB >> 8065869

Febrile infants at low risk for serious bacterial infection--an appraisal of the Rochester criteria and implications for management. Febrile Infant Collaborative Study Group.

J A Jaskiewicz1, C A McCarthy, A C Richardson, K C White, D J Fisher, R Dagan, K R Powell.   

Abstract

OBJECTIVE: Prospective studies were conducted to test the hypothesis that infants unlikely to have serious bacterial infections (SBI) can be accurately identified by low risk criteria.
METHODS: Febrile infants (rectal T > or = 38 degrees C) < or = 60 days of age were considered at low risk for SBI if they met the following criteria: 1) appear well; 2) were previously healthy; 3) have no focal infection; 4) have WBC count 5.0-15.0 x 10(9) cells/L (5000-15,000/mm3), band form count < or = 1.5 x 10(9) cells/L (< or = 1500/mm3), < or = 10 WBC per high power field on microscopic examination of spun urine sediment, and < or = 5 WBC per high power field on microscopic examination of a stool smear (if diarrhea). The recommended evaluation included the culture of specimens of blood, cerebrospinal fluid, and urine for bacteria. Outcomes were determined. The negative predictive values of the low risk criteria for SBI and bacteremia were calculated.
RESULTS: Of 1057 eligible infants, 931 were well appearing, and, of these, 437 met the remaining low risk criteria. Five low risk infants had SBI including two infants with bacteremia. The negative predictive value of the low risk criteria was 98.9% (95% confidence interval, 97.2% to 99.6%) for SBI, and 99.5% (95% confidence interval, 98.2% to 99.9%) for bacteremia.
CONCLUSIONS: These data confirm the ability of the low risk criteria to identify infants unlikely to have SBI. Infants who meet the low risk criteria can be carefully observed without administering antimicrobial agents.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8065869

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  59 in total

Review 1.  Unexplained fever in young children: how to manage severe bacterial infection.

Authors:  Itzhak Brook
Journal:  BMJ       Date:  2003-11-08

2.  New sandwich-type enzyme-linked immunosorbent assay for human MxA protein in a whole blood using monoclonal antibodies against GTP-binding domain for recognition of viral infection.

Authors:  Mizuho Kawamura; Akira Kusano; Akiko Furuya; Nobuo Hanai; Hideki Tanigaki; Akihito Tomita; Akira Horiguchi; Kyosuke Nagata; Toshiko Itazawa; Yuichi Adachi; Yoshie Okabe; Toshio Miyawaki; Hiroaki Kohno
Journal:  J Clin Lab Anal       Date:  2012-05       Impact factor: 2.352

3.  Case 1: Neonatal labial swelling.

Authors:  Ryan W Smith; Michelle Gordon
Journal:  Paediatr Child Health       Date:  2009-07       Impact factor: 2.253

4.  Immature neutrophils in young febrile infants.

Authors:  Sriram Ramgopal; Lorne W Walker; Andrew J Nowalk; Andrea T Cruz; Melissa A Vitale
Journal:  Arch Dis Child       Date:  2019-06-20       Impact factor: 3.791

5.  Management of fever without source in children: Changing times.

Authors:  James D Kellner
Journal:  Paediatr Child Health       Date:  2003-02       Impact factor: 2.253

6.  Association between Clinical Outcomes and Hospital Guidelines for Cerebrospinal Fluid Testing in Febrile Infants Aged 29-56 Days.

Authors:  Kao-Ping Chua; Mark I Neuman; J Michael McWilliams; Paul L Aronson
Journal:  J Pediatr       Date:  2015-10-21       Impact factor: 4.406

7.  Approach to the febrile child: A challenge bridging the gap between the literature and clinical practice.

Authors:  Jean-Bernard Girodias; Benoit Bailey
Journal:  Paediatr Child Health       Date:  2003-02       Impact factor: 2.253

8.  The accuracy of clinical symptoms and signs for the diagnosis of serious bacterial infection in young febrile children: prospective cohort study of 15 781 febrile illnesses.

Authors:  Jonathan C Craig; Gabrielle J Williams; Mike Jones; Miriam Codarini; Petra Macaskill; Andrew Hayen; Les Irwig; Dominic A Fitzgerald; David Isaacs; Mary McCaskill
Journal:  BMJ       Date:  2010-04-20

9.  Changing epidemiology of serious bacterial infections in febrile infants without localizing signs.

Authors:  Kevin Watt; Erica Waddle; Ravi Jhaveri
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

10.  The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria.

Authors:  Michael T Ambler; Lilly M Dubowitz; Ratree Arunjerdja; Eh Paw Hla; Kyaw Lay Thwai; Jacher Viladpainguen; Pratap Singhasivanon; Christine Luxemburger; François Nosten; Rose McGready
Journal:  Malar J       Date:  2009-09-02       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.